Research use only. The materials discussed on this page are sold exclusively for in vitro laboratory research. They are not for human or veterinary use, and nothing here is medical advice or a claim of benefit. Animal-model and clinical data are mentioned only as cited published literature.
GHK-Cu and Argireline are two essential peptides in in vitro cosmetology research. Their mechanisms are radically different: GHK-Cu modulates the extracellular matrix and tissue regeneration, while Argireline is an analog of the SNAP-25 N-terminal chain that inhibits neurotransmitter release. This comparison is intended for skin biology researchers.
The two compounds
- GHK-Cu — view the GHK-Cu research product page
- Argireline (Acetyl Hexapeptide-3) — view the Argireline (Acetyl Hexapeptide-3) research product page
Comparison table
| Property | GHK-Cu | Argireline (Acetyl Hexapeptide-3) |
|---|---|---|
| Class | Copper-tripeptide (metallopeptide complex) | Acetylated hexapeptide (SNAP-25 analog) |
| Sequence | Gly-His-Lys + Cu²⁺ | Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 |
| Mechanism | Modulates collagen, elastin, MMPs, antioxidant | Inhibits neurotransmitter release (SNARE) |
| Biological target | Dermal fibroblasts, ECM | Neuromuscular junction (in vitro) |
| Skin research effect | Extracellular-matrix and fibroblast biology (in vitro) | Models of expression-related wrinkle biology (in vitro) |
| Form | Blue lyophilized powder (copper) | White lyophilized powder |
| Applications | Skin healing, hair research, ECM | Cutaneous neuromuscular research, vasoconstriction |
| Discovery | Loren Pickart, 1973 | Lipotec, 2001 (Spain) |
| Purity documentation | Batch CoA (HPLC) | Batch CoA (HPLC) |
Research contexts
Literature contexts for GHK-Cu
Fibroblast studies, skin healing models, hair research (GHK-Cu and follicles), ECM and collagen, antioxidant.
Literature contexts for Argireline (Acetyl Hexapeptide-3)
Neurotransmitter release studies, striated muscle contraction models, cosmetic research on expression wrinkles.
Mechanisms of action
GHK-Cu
GHK-Cu is a complex formed by the Gly-His-Lys tripeptide and a copper ion (Cu²⁺). It modulates the expression of over 4,000 genes (transcriptomic analysis), stimulates collagen and glycosaminoglycan synthesis, and inhibits MMP-2/MMP-9 metalloproteinases. Antioxidant action via SOD.
Argireline (Acetyl Hexapeptide-3)
Argireline (Acetyl Hexapeptide-3) is an N-terminal fragment of SNAP-25, a SNARE complex protein responsible for synaptic vesicle fusion. It competes with endogenous SNAP-25, inhibiting acetylcholine release and thus muscle contraction — partially mimicking botulinum toxin action but much more weakly.
Combined research context
Both peptides are frequently studied in combination in in vitro cosmetic research: GHK-Cu for structural regeneration (collagen, ECM) and Argireline for contraction inhibition (dynamic wrinkles). Neither is approved as a drug.
Related research products
Axion Research Peptides supplies research-grade peptides for in vitro use, with a batch certificate of analysis. Browse GHK-Cu, Argireline (Acetyl Hexapeptide-3) or the full research catalog.
Frequently asked questions
Why is GHK-Cu blue?
Because of the copper-peptide complex (Cu²⁺). The characteristic blue color results from copper coordination by the nitrogen and oxygen atoms of the Gly-His-Lys tripeptide.
Is Argireline comparable to botulinum toxin?
Mechanistically yes (action on the SNARE complex), but its effect is much weaker and reversible. Botulinum toxin enzymatically cleaves SNAP-25; Argireline is only a weak competitive inhibitor.
Can they be studied together?
Yes — their mechanisms are non-overlapping (structural regeneration vs neuromuscular inhibition), making them a frequent combination in cosmetic research protocols.
Is GHK-Cu studied for hair loss?
Yes — in vitro studies on human hair follicles show that GHK-Cu can modulate dermal papilla cell proliferation and expression of hair growth markers (research only).
Are these peptides approved in the USA?
They are not approved as drugs by the FDA. Argireline and GHK-Cu can be used in consumer cosmetics (subject to FDA cosmetic regulations and EU Regulation 1223/2009), but the Axion Research Peptides versions are intended exclusively for in vitro scientific research.
Scientific references
- Pickart L, Margolina A., 2018 — GHK-Cu review, Int J Mol Sci.
- Blanes-Mira C et al., 2002 — Argireline SNAP-25, Int J Cosmet Sci.
Regulatory disclaimer
The peptides discussed in this comparison are not approved by the FDA, EMA, MHRA, or any regulatory agency for human or veterinary clinical use, except where a specific approved product is named (for example, tesamorelin as Egrifta). They are sold by Axion Research Peptides exclusively for in vitro scientific research. This page summarizes published literature and is neither medical advice nor a recommendation for clinical use.
